↓ Skip to main content

NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment

Overview of attention for article published in Frontiers in Pharmacology, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
22 X users
peer_reviews
1 peer review site

Citations

dimensions_citation
99 Dimensions

Readers on

mendeley
140 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
Published in
Frontiers in Pharmacology, August 2019
DOI 10.3389/fphar.2019.00877
Pubmed ID
Authors

Ming-Feng Xia, Hua Bian, Xin Gao

X Demographics

X Demographics

The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 140 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 16%
Student > Ph. D. Student 17 12%
Student > Bachelor 16 11%
Researcher 10 7%
Other 7 5%
Other 22 16%
Unknown 46 33%
Readers by discipline Count As %
Medicine and Dentistry 33 24%
Biochemistry, Genetics and Molecular Biology 19 14%
Nursing and Health Professions 5 4%
Agricultural and Biological Sciences 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 27 19%
Unknown 46 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2022.
All research outputs
#3,055,048
of 25,837,817 outputs
Outputs from Frontiers in Pharmacology
#1,297
of 20,002 outputs
Outputs of similar age
#59,408
of 359,855 outputs
Outputs of similar age from Frontiers in Pharmacology
#37
of 335 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,002 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,855 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 335 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.